In the past week, AMGN stock has gone down by -1.75%, with a monthly decline of -1.20% and a quarterly plunge of -12.47%. The volatility ratio for the week is 1.64%, and the volatility levels for the last 30 days are 1.69% for AMGEN Inc. The simple moving average for the last 20 days is -3.10% for AMGN stock, with a simple moving average of -1.91% for the last 200 days.
Is It Worth Investing in AMGEN Inc. (NASDAQ: AMGN) Right Now?
The price-to-earnings ratio for AMGEN Inc. (NASDAQ: AMGN) is above average at 21.28x. The 36-month beta value for AMGN is also noteworthy at 0.61. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 3 rating it as “overweight,” 15 rating it as “hold,” and 0 rating it as “sell.”
The public float for AMGN is 534.60M, and at present, short sellers hold a 1.96% of that float. The average trading volume of AMGN on April 17, 2024 was 2.93M shares.
AMGN) stock’s latest price update
AMGEN Inc. (NASDAQ: AMGN)’s stock price has plunge by 0.05relation to previous closing price of 265.51. Nevertheless, the company has seen a -1.75% plunge in its stock price over the last five trading sessions. Market Watch reported 2024-04-16 that A couple of big-picture trends in biotech could add up to a nice investment opportunity. First, corporate buyouts are back in style.
Analysts’ Opinion of AMGN
Leerink Partners, on the other hand, stated in their research note that they expect to see AMGN reach a price target of $318, previously predicting the price at $324. The rating they have provided for AMGN stocks is “Market Perform” according to the report published on February 07th, 2024.
Daiwa Securities gave a rating of “Buy” to AMGN, setting the target price at $320 in the report published on December 21st of the previous year.
AMGN Trading at -5.52% from the 50-Day Moving Average
After a stumble in the market that brought AMGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.43% of loss for the given period.
Volatility was left at 1.69%, however, over the last 30 days, the volatility rate increased by 1.64%, as shares sank -1.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.81% lower at present.
During the last 5 trading sessions, AMGN fell by -1.75%, which changed the moving average for the period of 200-days by +20.11% in comparison to the 20-day moving average, which settled at $273.86. In addition, AMGEN Inc. saw -7.77% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AMGN starting from Grygiel Nancy A., who sale 2,096 shares at the price of $273.03 back on Dec 04 ’23. After this action, Grygiel Nancy A. now owns 10,874 shares of AMGEN Inc., valued at $572,276 using the latest closing price.
Graham Jonathan P, the EVP, Gen. Counsel & Secy. of AMGEN Inc., sale 10,000 shares at $272.81 during a trade that took place back on Nov 08 ’23, which means that Graham Jonathan P is holding 28,078 shares at $2,728,136 based on the most recent closing price.
Stock Fundamentals for AMGN
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.7 for the gross margin
The net margin for AMGEN Inc. stands at 0.24. The total capital return value is set at 0.12. Equity return is now at value 135.79, with 8.28 for asset returns.
Based on AMGEN Inc. (AMGN), the company’s capital structure generated 0.91 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 10.37. The interest coverage ratio of the stock is 3.15.
Currently, EBITDA for the company is 14.8 billion with net debt to EBITDA at 4.43. When we switch over and look at the enterprise to sales, we see a ratio of 6.95. The receivables turnover for the company is 3.55for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.
Conclusion
In summary, AMGEN Inc. (AMGN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
